Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02651597
Other study ID # B2015:142
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2016
Est. completion date December 10, 2016

Study information

Verified date April 2021
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives are to assess the effects of high viscosity vs. medium and low viscosity oat β-glucan on post-prandial glycemic response in healthy adult participants.


Description:

The trial will be a 3 week double-blinded, randomized, cross-over design with 3 treatment intervention (oatmeal breakfasts costain low, medium and high viscosity of beta glucan) periods separated by about 5-7 days washout period. Normoglycemic (<5.6 mmol/L) males and females (12 of each) of age 18-45 y with a body mass index (BMI) of 18.5-29.9 kg/m2 will be recruited. Each participant will receive each of the following breakfast foods in a random order: 1) oat meal containing low viscosity beta glucan; 2) oat meal containing medium viscosity beta glucan; 3) oat meal containing high viscosity beta glucan. The participants will be asked to consume one of the breakfast foods during each visit. Following each blood sample, appetite, physical comfort, energy/fatigue, and palatability of treatments will be measured by visual analogue scales (VAS). Glucose measurements: Capillary blood will be collected during each visit by finger prick. Blood will be collected at fasting and at 15, 30, 45, 60, 90 and 120 minutes after the first bite/sip of the test product according to the Clinical Laboratory Standard Institute (CLSI) guidelines. Blood glucose will be measured in finger prick blood samples by glucose meters . Males will be scheduled for three sessions over 3 weeks. Women will be scheduled during the first two weeks of their menstrual cycle (follicular phase), once per week. During the wash-out days (5 - 7 days between each phase), participants can go about their daily activities unrestricted with the following exception: no strenuous activity or alcohol consumption on the days before the clinic visit. The investigators will ask that participants go to sleep at the same time on the days before the sessions.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 10, 2016
Est. primary completion date December 10, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Normoglycemic (<5.6 mmol/L) - BMI= 18.5-29.9 kg/m² Exclusion Criteria: - A change in medication (dose or type) or medical event requiring hospitalization within the past month. - Daily tobacco use. - Eat meals at irregular or unusual times. - Food allergy, aversion or unwillingness to eat study foods. - Use of any prescription or non-prescription drug, herbal or nutritional supplement known to affect blood sugar. - Presence of a gastrointestinal disorder. - Currently pregnant or lactating.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oatmeal


Locations

Country Name City State
Canada Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
University of Manitoba PepsiCo Global R&D

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood Glucose Total area under the curve (iAUC, mmol*min/L) for glucose 0-200 mins
Secondary Appetite (visual analogue scales) Measured by VAS questionnaire at 12 time points used to calculate area under curve 0-200 mins
Secondary Physical Comfort Measured by VAS questionnaire at 12 time points used to calculate area under curve 0-200 mins
Secondary Energy/Fatigue Measured by VAS questionnaire at 12 time points used to calculate area under curve 0-200mins
Secondary Palatability Measured by VAS questionnaire at 12 time points used to calculate area under curve at 5 mins
See also
  Status Clinical Trial Phase
Completed NCT02596776 - Cold Induced Changes in White Adipose Early Phase 1
Completed NCT02994420 - Endocrine and Neural Control of Eating in Women